De Novo device
Stanza
Swing Therapeutics, Inc. · Computerized Behavioral Therapy Device For The Treatment Of Fibromyalgia Symptoms (QWI, Class II) · First FDA decision May 9, 2023, newest May 9, 2023Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
2
Naming "Stanza"
MAUDE reports
0
Brand "Stanza", since 2015
PubMed studies
37
Mentioning "Stanza"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Stanza
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- StanzaNew device typeBreakthroughDe Novo
DEN220083 · Decided May 9, 2023 · 169 days after receipt
Device type: Computerized Behavioral Therapy Device For The Treatment Of Fibromyalgia Symptoms (QWI) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent ClaudicationLocal determinationIn effectL37774Palmetto GBAUpdated Jan 12, 2024
- Autologous Cellular Immunotherapy Treatment of Metastatic Prostate CancerNational analysisReview closedCAG-00422NUpdated Nov 19, 2026
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
- Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)National analysisReview closedCAG-00449NUpdated Sep 23, 2026
- Outpatient Intravenous Insulin Treatment (Therapy)National analysisReview closedCAG-00410NUpdated Sep 18, 2026
- Intensive Behavioral Therapy for ObesityNational analysisReview closedCAG-00423NUpdated Sep 18, 2026
- Intensive Behavioral Therapy for Cardiovascular DiseaseNational analysisReview closedCAG-00424NUpdated Sep 18, 2026
- Intensive Behavioral Therapy for ObesityNational determinationOn the books210.12Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Stanza", any status and sponsor, newest update first.
- Self-guided Acceptance and Commitment Therapy-based Digital Smartphone Application for Management of FibromyalgiaPivotal-lookingRecruiting
Fundació Sant Joan de DéuAcademic, hospital or other
NCT05962437 · 360 participants (planned) · Start Jan 1, 2024 · Primary completion Mar 31, 2027
Device: Self-guided digital Acceptance and Commitment Therapy; FM symptom tracking app (FM-ST) · For: Fibromyalgia
Sites: Barcelona, Spain; Sant Boi de Llobregat, Spain
- Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) SystemCompleted
480 BiomedicalNot on our public-company list
NCT02097082 · 28 participants · Start Oct 2013 · Primary completion Mar 30, 2016
Device: STANZA Drug-eluting resorbable Scaffold · For: Peripheral Arterial Disease; Intermittent Claudication; Vascular Diseases and 1 more
Sites: Graz, Austria; Vienna, Austria; Bad Krozingen, Germany · 9 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Stanza", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QWI
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Stanza"[tiab]. The summary above synthesizes these.
- MedLexSp - a medical lexicon for Spanish medical natural language processing.
Campillos-Llanos L · J Biomed Semantics · 2023Research Support, Non-U.S. Gov't
- Got Selenium?
Oremland RS · FEMS Microbiol Ecol · 2020
- Growth of the silverside Atherinella brasiliensis in a subtropical estuary with some insights concerning the weight-length relationship.
Carvalho BM, Barradas JRS, Fontoura NF, et al. · An Acad Bras Cienc · 2017
- A bridge too far for artificial intelligence?: Automatic classification of stanzas in Spanish poetry.
Pérez Pozo Á, de la Rosa J, Ros S, et al. · J Assoc Inf Sci Technol · 2022
- Clues cue the smooze: rhyme, pausing, and prediction help children learn new words from storybooks.
Read K · Front Psychol · 2014
- Return of warm conditions in the southeastern Bering Sea: Phytoplankton - Fish.
Duffy-Anderson JT, Stabeno PJ, Siddon EC, et al. · PLoS One · 2017
- Using Recurrent Neural Networks to Extract High-Quality Information From Lung Cancer Screening Computerized Tomography Reports for Inter-Radiologist Audit and Feedback Quality Improvement.
Zhang Y, Grant BMM, Hope AJ, et al. · JCO Clin Cancer Inform · 2023Research Support, Non-U.S. Gov't
- Evaluating Natural Language Processing Packages for Predicting Hospital-Acquired Pressure Injuries From Clinical Notes.
Gu S, Lee EW, Zhang W, et al. · Comput Inform Nurs · 2024
- Calcite moonmilk of microbial origin in the Etruscan Tomba degli Scudi in Tarquinia, Italy.
Cirigliano A, Tomassetti MC, Di Pietro M, et al. · Sci Rep · 2018Research Support, Non-U.S. Gov't
- Infantile seborrheic dermatitis: a pediatric Siddha medicine treatise.
Thambyayah M, Amuthan A · Clin Dermatol · 2015
- Biomedical and clinical English model packages for the Stanza Python NLP library.
Zhang Y, Zhang Y, Qi P, et al. · J Am Med Inform Assoc · 2021
- Study protocol for a three-arm randomized controlled trial investigating the effectiveness, cost-utility, and physiological effects of a fully self-guided digital Acceptance and Commitment Therapy for Spanish patients with fibromyalgia.
Gallego A, Serrat M, Royuela-Colomer E, et al. · Digit Health · 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.